Regeneration Technologies Inc.

Guy Mayer was named president for RTI Biologics in February 2008. He joined Tutogen Medical as president and chief executive officer in January 2005. In his role at RTI Biologics, Mayer oversees all aspects of marketing and distribution through medical device companies. Prior to Tutogen, Guy served for two years as chairman and CEO of Visen Medical, a private biotech company focused on Molecular Imaging technologies. Prior to Visen, he served three years as president and CEO of ETEX Corporation, a private biomedical company based in Cambridge, Mass. For 13 years prior to joining ETEX, Mayer held various senior positions at Zimmer Inc., then a division of Bristol Myers Squibb, with sales in excess of $1.2 billion. Guy is a graduate of the University of Ottawa and currently serves on the Board of Directors of Spire Corporation, a public company, as well as a number of private companies.

Hartill was named chief scientific officer in March 2007 and vice president of quality assurance and regulatory affairs in January 2003. She joined RTI as executive director of quality assurance and regulatory affairs in 2001. For 15 years prior, she served as a freelance consultant working with many major and start-up biotechnology and medical device companies worldwide. Earlier, she worked for the British Standards Institute (UK) and the Ministry of Defence (UK). Hartill earned a bachelor's degree with honors in health sciences from Birmingham University Medical School in England, as well as a master's degree in management from the University of Wolverhampton in England. She also earned master's level credits in sterilization science from Manchester University.

Bob Plessinger joined the EastWest Institute in 2002, and serves as the Director for Information Technology. Prior to joining EWI, Bob developed internet based software for a variety of private companies and U.S. government agencies. His work experience includes working as a consultant for the Judge Advocate General of the U.S. Army; Regeneration Technologies, Inc.; Appix, Inc.; Advanced Technology Systems, and the U.S. Department of Housing and Urban Development. Bob is a graduate of Shippensburg University of Pennsylvania in the United States.

Dennis Tomisaka joined Nanotherapeutics in 2005 as VP of Operations and Product Development. Mr. Tomisaka has extensive experience and success in leading multi-functional, technology teams in the development and successful commercialization of products in the biotechnology, implantable, and disposable medical device markets at companies including Johnson & Johnson, Baxter Healthcare and Regeneration Technologies. He earned his B.S. degree in Chemical Engineering from the University of California at Berkeley, his M.S.E. degree in Biomedical Engineering from Arizona State University, and his MBA. from The Ohio State University. He has four issued U.S. patents and has had membership and certification training in the Project Management Institute (PMI) and the Product Development Management Association (PDMA).

Michael J. Odrich has served as a member of RTI's Board of Directors since February 1998. Odrich has served as a director of Active Software, Inc. since 1997 and PEMSTAR, Inc. since 1998. Since 1986, he has held various banking positions at Lehman Brothers Inc. Currently he is a managing director, head of the venture capital business and has served as president of Lehman Brothers Venture Associates since 1999. Odrich holds a bachelor's degree from Stanford University and received a masters of business administration degree from Columbia University.

Phillip R. Chapman has served as a member of RTI's Board of Directors since February 1998. He is the president of Venad Administrative Services, Inc. and has been a general partner of Adler & Company since 1995. From 1991 until 1995, he served as a principal of Adler & Company. From 1981 until 1989, Chapman served as a senior consultant at Booz Allen & Hamilton International. Chapman is also a director of Shells Seafood Restaurants, Inc. He holds a bachelor's degree and masters of business administration degree from Columbia University.